Cross-referencing clinical data
A pairing appears on this page only when a trial gave both ingredients together and measured the result. Quinine sulphate has none that clears that bar.
Stitching two separate single-ingredient studies into a pairing is the one thing this engine will not do. When a study of the combination itself holds up at source, it lands here with its citation.
No invented synergy. Where actives were studied on their own rather than together, the record shows each on its own evidence, never a combined effect no trial measured.
Research strength. Research strength says how much work stands behind the combination. It is never a product score.
Independent record. Every finding is cited to a named trial, dated, and never written by the brand.
20 pairings are live across the library today. Checked 20 July 2026.
No study gave these as a pair, so they are not in the card above. But the reason they belong together is settled biochemistry, not a guess, so it is worth knowing.
Weak bases are excreted more readily in acidic urine because they stay ionised and cannot be reabsorbed across the tubule. Alkalinising the urine with bicarbonate shifts more quinine to the un-ionised form, which is reabsorbed, so plasma levels run higher for longer. That direction matters because quinine has a narrow margin between useful and unpleasant. This is a documented pharmacokinetic relationship, not a benefit pairing.
Quinine is an alkaloid with the aromatic and basic features that charcoal binds well. Taken in the same window, charcoal will cut how much quinine reaches circulation. Anyone using charcoal for unrelated reasons should separate it from any alkaloid-containing product by several hours.
Quinine's principal metabolic route is CYP3A4 hydroxylation to 3-hydroxyquinine. Piperine slows CYP3A4 and P-glycoprotein, so co-exposure would be expected to raise quinine exposure rather than lower it. The direction is predictable from the enzymology even though the specific pair has not been measured in people. With a compound this narrow-margined, an unmeasured push upward is worth naming.
Quinine reduces the excitability of the motor end plate and lengthens the muscle refractory period, effects that sit downstream of calcium movement in the muscle fibre. This is mechanistic, from muscle physiology work, and is not a statement that calcium intake changes anything a person would notice. Read it as background to why quinine turns up in muscle-related contexts at all.
Tannins and catechins precipitate alkaloids out of aqueous solution, a chemistry used for centuries to isolate them. In the gut this means a strongly polyphenolic drink taken alongside an alkaloid can lower what gets absorbed. The size of the effect depends on polyphenol load and timing and has not been quantified for this pair.
Magnesium and quinine occupy the same shelf in the cramping conversation, which makes co-use likely even though no shared pathway links them. Magnesium acts on neuromuscular excitability through NMDA and calcium channel modulation; quinine acts on the muscle membrane directly. Overlap in intent is not overlap in mechanism, and neither should be assumed to substitute for medical advice.
Quinoline compounds interact with heme, which is the basis of quinine's classical pharmacology in the parasite digestive vacuole. That is parasite biochemistry and does not transfer to a person's iron status. It is listed here so the heme connection is not mistaken for an iron-nutrition interaction.
Nothing specific on file for Quinine sulphate. Match the label to the daily amount above, and tell your doctor what you take.
Not medical advice. Show the label to your pharmacist.1 source behind our Quinine sulphate verdict: peer-reviewed studies and registered clinical trials. Every one links straight to PubMed, the journal, or ClinicalTrials.gov. Read them yourself.
Evidence surfaced via Semantic Scholar (Allen Institute for AI) and ClinicalTrials.gov. Ranked by study type and citation weight, not cherry-picked.
Read this carefully. These are 1,730 voluntary, unverified reactions reported to the FDA (openFDA). The number mostly reflects how popular Quinine sulphate is, not how risky it is. A report is not proof Quinine sulphate caused anything. It is a signal of what to watch for, nothing more.
Source: openFDA adverse-event reports. Voluntary reporting, not an incidence rate.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.